Evidence map›Paper›PMID 41093347›Full record

ArticleBMJ open2025

Ethnic differences in plasma aldosterone concentration and regulatory mechanisms of aldosterone: protocol for a systematic review and meta-analysis.

Aditya Sharma, Gisele Bentley, Spoorthy Kulkarni, Ian Wilkinson

Abstract read
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aditya SharmaDepartment of Medicine, University of Cambridge, Cambridge, UK as3670@cam.ac.uk.ORCID http://orcid.org/0009-0004-1832-7666
Gisele BentleyDepartment of Medicine, University of Cambridge, Cambridge, UK.
Spoorthy KulkarniDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-2827-214X
Ian WilkinsonDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-6598-9399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBlack ethnic cohorts, when compared with white cohorts, have disproportionately higher rates of essential hypertension and related complications. Ethnic differences in the renin-angiotensin-aldosterone system have been identified in black ethnic cohorts displaying a low-renin, salt-sensitive phenotype in comparison to white individuals. Studies have highlighted lower levels of aldosterone in black cohorts compared with white cohorts. However, when renin is considered, in the form of the aldosterone-renin ratio (ARR), the ARR is higher in black cohorts. The Framingham study highlighted that people in the upper quartile for baseline aldosterone were more likely to have a higher blood pressure and develop hypertension at 4 year follow-up. Therefore, the inappropriately suppressed aldosterone may be contributing to the ethnic differences in hypertension prevalence and prognosis. METHODS AND ANALYSIS: Four databases will be searched (MEDLINE, Embase, Scopus and Cochrane Library) to identify eligible studies from database creation to August 2025. Two investigators will independently review the search results and document reasons for full-text exclusions. The main outcomes are to assess if there are ethnic differences in baseline aldosterone, baseline plasma renin activity (PRA) and ARR. We will also look at ethnic differences in regulatory mechanisms of aldosterone, such as serum potassium and 24 hour urinary electrolytes, that may explain the potential differences in aldosterone and ARR in black and white ethnic cohorts. Studies looking at normotensive and hypertensive individuals will be included. Studies in paediatric populations (<18 years) will be excluded. We will include studies without language restriction. Risk of bias assessment will be completed with a modified Newcastle-Ottawa scale. Subgroup analysis and sensitivity analyses will be completed to verify the accuracy of the study results and the consistency of the inferences. ETHICS AND DISSEMINATION: As this review will involve analysis of previously published data, ethical approval is not required. The results will be submitted to a peer-reviewed journal. PROSPERO REGISTRATION NUMBER: CRD420251025642.

Indexed as

AldosteroneHypertensionBlack PeopleHumansMeta-Analysis as TopicReninRenin-Angiotensin SystemResearch DesignSystematic Reviews as TopicWhite PeopleAldosteroneReninCLINICAL PHARMACOLOGYGeneral endocrinologyHypertension

Identifiers

PMID41093347
PMCPMC12530402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.